trending Market Intelligence /marketintelligence/en/news-insights/trending/aXPWbKmGMxdOeWeuQ6zXww2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

IRDAI approves Max India's stake divestment in Max Bupa

Infrastructure Issues: Tools to Dig Deep on Potential Risks

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools


IRDAI approves Max India's stake divestment in Max Bupa

The Insurance Regulatory and Development Authority of India approved True North Fund VI LLP's purchase of Max India Ltd.'s 51% stake in Max Bupa Health Insurance Co. Ltd.

Max India announced the all-cash transaction in February. The acquisition, which is now set to close within the next few weeks, valued Max Bupa at an enterprise value of 10.01 billion rupees.

Max Bupa is a joint venture between U.K.-based Bupa and Max India.

As of Dec. 2, US$1 was equivalent to 71.66 Indian rupees.